Key result
Age-adjusted US hypertension-related mortality climbs ~36% from 1999 to 2016.
Why the study?
Hypertension-related mortality has been increasing, but limited information exists concerning rate, temporal, secular, and geographic trends in the United States.
Observational (n=1,079,913)
Hypertension-related mortality in the US has accelerated since 2011, particularly among middle-aged and older adults, highlighting a growing public health challenge.
Answers are grounded in this paper and cite their sources.
Accelerating hypertension mortality may warrant renewed BP control emphasis in middle-aged adults; supports further research into post-2011 drivers.
BACKGROUND: Hypertension-related mortality has been increasing in recent years; however, limited information exists concerning rate, temporal, secular, and geographic trends in the United States. METHODS AND RESULTS: Using CDC death certificate data spanning 1999-2016, we sought to delineate trends in deaths attributable to an underlying cause of hypertension using joinpoint regression and proportion testing. From 1999-2016, the hypertension-related mortality rate increased by 36.4% with an average annual percent change (AAPC) of 1.8% for individuals ≥ 35 years of age. Interestingly, there was a notable acceleration in the AAPC of hypertension mortality between 2011 and 2016 (2.7% per year). This increase was due to a significant uptick in mortality for individuals ≥ 55 years of age with the greatest AAPC occurring in individuals 55-64 (4.5%) and 65-74 (5.1%) years of age. Increased mortality and AAPC were pervasive throughout sex, ethnicity, and White and American Indian or Alaska Native race, but not Black or African American race. From 2011-2016, there were significant increases in AAPC for hypertension-related mortality with contributing causes of atrial fibrillation, heart failure, diabetes, obesity, and vascular dementia. Elevated mortality was observed for conditions with a contributing cause of hypertension that included chronic obstructive pulmonary disease, diabetes, Alzheimer's, Parkinson's, and all types of falls. Geographically, increases in AAPCs and mortality rates were observed for 25/51 States between 2011 and 2016. CONCLUSIONS: Our results indicate hypertension-related mortality may have accelerated since 2011 for middle-aged and older Americans, which may create new challenges in care and healthcare planning.
No takes yet. Share an insight, caveat, or question.
Forrester et al. (2020) conducted an observational in Hypertension-related mortality (n=1,079,913). Time period (1999-2016) vs. 1999 baseline was evaluated on Age-adjusted hypertension-related mortality rate (per 100,000) (36.4% increase). Between 1999 and 2016, the age-adjusted hypertension-related mortality rate in the US increased by 36.4%, with a notable acceleration to a 2.7% average annual increase between 2011 and 2016.
Synapse has enriched 10 related papers. Consider them for comparative context: